- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
NEW YORK ( TheStreet) -- Genomic Health (Nasdaq: GHDX) hit a new 52-week high Monday as it is currently trading at $32.12, above its previous 52-week high of $32.03 with 91,931 shares traded as of 12 p.m. ET. Average volume has been 144,500 shares over the past 30 days. Genomic Health has a market cap of $902.8 million and is part of the health care sector and health services industry. Shares are up 23.4% year to date as of the close of trading on Friday. Genomic Health, Inc., a molecular diagnostics company, engages in the development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. The company has a P/E ratio of 103.6, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.